Trial reportBMC public health2025
Engaging underrepresented patient groups in specialised treatment - qualitative results from the PROVIDE-C randomised trial on integrated mental health video consultations for depression and anxiety.
Trial report in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04316572 (ImPROving Cross-sectoral Collaboration Between Primary and Psychosocial Care), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
ImPROving Cross-sectoral Collaboration Between Primary and Psychosocial Care: A Randomised Controlled Superiority Trial to Compare the Effectiveness of a Mental Health Specialist VIDEo Consultations Model Versus Treatment as Usual in Patients With Depression or Anxiety Disorders in Primary Care
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental health specialist video consultations (MHSVC) offer a promising way to address the growing burden of depression and anxiety. However, their acceptance among groups with lower mental health care uptake and limited technology literacy remains underexamined.
objectiveThis study explores how underrepresented patients-elderly, rural, and male individuals with depression or anxiety-experience and accept MHSVC after participating in PROVIDE-C, a randomized trial evaluating a five-session MHSVC intervention in primary care.
methodsA qualitative interview study in rural Germany used inductive content analysis and the Technology Acceptance Model (TAM). TAM suggests that perceived usefulness and ease of use influence technology adoption.
resultsAmong 21 PROVIDE-C participants, attitudes toward MHSVC were largely positive. Patients found the intervention useful for therapeutic alliance, symptom relief, and treatment measures, with many preferring continued sessions. Prior mental health care experience and strong primary care relationships increased acceptance. Some patients, already familiar with videoconferencing due to COVID-19, adapted easily, while those with lower technology literacy relied on technical support in primary care to engage with MHSVC for the first time.
conclusionsEmbedding MHSVC in primary care enhances access for patients hesitant about mental health treatment or unfamiliar with digital tools. The PROVIDE model effectively reaches underserved populations, namely elderly, rural patients, improving access to specialized care and reducing depression and anxiety symptoms, as evidenced by its demonstrated effectiveness.
trial registrationClinicalTrials.gov, United States National Institutes of Health NCT04316572. Prospectively, registered on 20 March 2020.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.